Biomarkers are required for the complex process of diagnosing and monitoring cancer treatment. They are used to identify tumors, investigate where they have come from and monitor how they are developing.
Partnering with a raw material supplier is essential for the development and manufacture of high-quality diagnostic tests required to diagnose and monitor cancer treatment efficacy as well as enable physicians to make informed decisions.
Critical raw materials when you need them
With our portfolio of reagents, you have access to the critical raw materials you need for your cancer marker immunoassay development projects – including biospecimens suitable for control samples.